The characterization of antibodies

Antigen Immunogen Manufacturer, species, antibody type Dilution
β-actin Synthetic β-cytoplasmic actin N-terminal peptide conjugated to KLH Sigma Aldrich (a5441), mouse, monoclonal 1:10,000
ED1 Rat spleen cells Bio-rad (MCA341), mouse, monoclonal 1:800
ERK1/2 Synthetic peptide corresponding to residues near the C-terminus of human p44 MAP kinase Cell Signaling Technology (#4695), rabbit, monoclonal 1:1,000
GFAP Purified GFAP from pig spinal cord was used as the immunogen Sigma-Aldrich (G3893), mouse, monoclonal 1:1,000
Iba1 Synthetic peptide of the C terminal of Iba1 WAKO (019–19741), rabbit, polyclonal 1:1,000
JNK1/2 Recombinant human JNK2 fusion protein Cell Signaling Technology (#9252), rabbit, polyclonal 1:1,000
p38 Peptide mapping at the C-terminus of p38α of mouse origin. Santa Cruz Biotechnology (sc-535), rabbit, polyclonal 1:1,000
p53 Amino acids 376-378 of human p53 Calbiochem (#OP03L), mouse, monoclonal 1:1,000
p-ERK1/2 Synthetic phosphopeptide corresponding to residues surrounding Thr202/Tyr204 of human p44 MAP kinase Cell Signaling Technology (#4370), rabbit, monoclonal 1:1,000
p-JNK1/2 Synthetic phosphopeptide corresponding to residues surrounding Thr183/Tyr185 of human SAPK/JNK Cell Signaling Technology (#9251), rabbit, polyclonal 1:1,000
p-p38 Tyr 182 phosphorylated p38a MAPK of human origin. Santa Cruz Biotechnology (sc-7973), mouse, polyclonal 1:1,000

ERK1/2, extracellular signal-regulated kinase1/2; GFAP, glial fibrillary acidic protein; Iba1, ionized calcium-binding adapter molecule 1; JNK1/2, c-jun-NH2-terminal kinase1/2; p-ERK1/2, phosphorylated form of extracellular signal-regulated kinase1/2; p-JNK1/2, phosphorylated form of c-jun-NH2- terminal kinase1/2; p-p38, phosphorylated form of p38.

Exp Neurobiol 2022;31:54~64 https://doi.org/10.5607/en21030
© Exp Neurobiol